August 10, 2015

According to the Substance Abuse Mental Health Services Administration, more than 24.5 million people age 12 or older in the U.S. (9.4% of the population) live with substance use disorders.

August 10, 2015
According to Sprout Pharmaceuticals, approximately one-in-three women in the United States suffer from low sexual desire, and one-in-10 women (16 million women total) are distressed by it.
August 10, 2015

In order to ensure that patients receive treatment for periodic paralysis, Taro will be partnering with Diplomat Pharmacy, where patients and caregivers will receive treatment access and support. 

August 4, 2015
The Food and Drug Administration has approved Aprecia Pharmaceuticals’ Spritam (levetiracetam), an epilepsy treatment that is the first FDA-approved drug that uses 3D printing technology. 
August 4, 2015

More than 28% of those surveyed fill 20 or more prescriptions per year but only half of those know about prescription savings cards. 

August 3, 2015

The National Association of Boards of Pharmacy last week released a progress report urging state and federal regulation for the thousands of websites that illegally distribute medications.

July 31, 2015

In late July, the Government Accountability Office released a report on how the lack of effective communications between the Drug Enforcement Agency and both pharmaceutical distributors and chain pharmacy headquarters has impacted legitimate access to pain medicines. "The agency’s report further validates the need for bipartisan, bicameral legislation," according to NACDS.

July 28, 2015

A GAO report released Monday suggests that the Drug Enforcement Agency should take steps to improve communications with pharmacists, manufacturers. 

July 27, 2015

The FDA has approved Daklinza (daclatasvir), in combination with sofosbuvir, in treatment for chronic hepatitis C virus genotype 3 infections.  

July 27, 2015

The Food and Drug administration announced Friday that it had approved Praluent (alirocumab), a cholesterol-lowering PCSK9 inhibitor injection. 

July 27, 2015

As the sole U.S. supplier of fluoxymesterone, Upsher-Smith sought a way to renew the product’s availability after the company’s initial API manufacturer discontinued its supply. 

July 24, 2015

On Friday, Stichting Preferred Shares Mylan, an independent foundation established in the Netherlands, announced that it would exercise its full call option to purchase 488,388,431 preferred shares in Mylan.

July 24, 2015

The Food and Drug Administration announced Friday that it approved Technivie (ombitasvir, paritaprevir and ritonavir) for use in combination with ribavirin for the treatment of hepatitis C virus (HCV) genotype 4 infections in patients without scarring and cirrhosis.

July 24, 2015

The Food and Drug Administration announced Friday that it had approved Novartis’ Odomzo (sonidegib). The drug is meant to treat basal cell carcinoma, the most common form of advanced skin cancer.

July 22, 2015

Novartis will be able to introduce Sandoz’s Zarxio (filgrastim) after Sept. 2, the U.S. Court of Appeal for the Federal Circuit ruled Wednesday. 

July 20, 2015

Access to healthcare drove 82.9% more blood pressure screenings and 26.9% more diabetes screenings.

July 20, 2015

Patients surfing the content on Elsevier's Health Library can search by a specific condition or diagnosis or move through an easy-to-skim, A-to-Z list of healthcare topics.

July 17, 2015

Amneal Pharmaceuticals has introduced four new products since June.

July 16, 2015

Galderma Laboratories announced Thursday that the Food and Drug Administration had approved it Epiduo Forte Gel, an antibiotic-free daily treatment for acne vulgaris.

July 16, 2015

As many as 12% of pet owners have bought health insurance for their animals. And among millennials, that number jumps to 19%. 

July 16, 2015

Increasing access to birth control through the pharmacy may pose a challenge - will pharmacists who counsel patients on family planning be reimbursed for their efforts?

July 15, 2015

The Food and Drug Administration is exploring extending PDUFA through 2022. 

July 15, 2015

Almost half of all people in an employer wellness program and with a chronic condition learned of their health status through that wellness program.